2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide

C26H25F3N6O2S — CID 146413533

IUPAC2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide
SMILESCc1ccc(Cc2ccn3c(C(F)(F)F)nnc3c2C)cc1CN1CC2(CNC2)Oc2ncccc2S1=O
InChIInChI=1S/C26H25F3N6O2S/c1-16-5-6-18(10-19-7-9-35-22(17(19)2)32-33-24(35)26(27,28)29)11-20(16)12-34-15-25(13-30-14-25)37-23-21(38(34)36)4-3-8-31-23/h3-9,11,30H,10,12-15H2,1-2H3
InChIKeyBXCUATJZXFLMOF-UHFFFAOYSA-N
MW542.59 g/mol
LogP3.61
Rot. Bonds4

About 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide

2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide (PubChem CID 146413533) has the molecular formula C26H25F3N6O2S and a molecular weight of 542.59 g/mol. Its IUPAC name is 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide.

Molecular Properties

Compound Name2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide
PubChem CID146413533
Molecular FormulaC26H25F3N6O2S
Molecular Weight542.59 g/mol
Exact Mass542.17
IUPAC Name2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide
SMILESCc1ccc(Cc2ccn3c(C(F)(F)F)nnc3c2C)cc1CN1CC2(CNC2)Oc2ncccc2S1=O
InChIInChI=1S/C26H25F3N6O2S/c1-16-5-6-18(10-19-7-9-35-22(17(19)2)32-33-24(35)26(27,28)29)11-20(16)12-34-15-25(13-30-14-25)37-23-21(38(34)36)4-3-8-31-23/h3-9,11,30H,10,12-15H2,1-2H3
InChIKeyBXCUATJZXFLMOF-UHFFFAOYSA-N
XLogP3.61
TPSA84.65 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500542.59
LogP ≤ 53.61
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide?
The IUPAC name of 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide (CID 146413533) is 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide.
What is the SMILES notation for 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide?
The canonical SMILES for 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide is Cc1ccc(Cc2ccn3c(C(F)(F)F)nnc3c2C)cc1CN1CC2(CNC2)Oc2ncccc2S1=O.
What is the InChIKey of 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide?
The InChIKey is BXCUATJZXFLMOF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H25F3N6O2S/c1-16-5-6-18(10-19-7-9-35-22(17(19)2)32-33-24(35)26(27,28)29)11-20(16)12-34-15-25(13-30-14-25)37-23-21(38(34)36)4-3-8-31-23/h3-9,11,30H,10,12-15H2,1-2H3.
What are the key properties of 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide?
2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide has a molecular weight of 542.59 g/mol, XLogP of 3.61, 4 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[2-methyl-5-[[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]methyl]phenyl]methyl]spiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,3'-azetidine] 1-oxide is sourced from PubChem (CID 146413533), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).